These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 32601464)

  • 1. EGFR/Ras-induced CCL20 production modulates the tumour microenvironment.
    Hippe A; Braun SA; Oláh P; Gerber PA; Schorr A; Seeliger S; Holtz S; Jannasch K; Pivarcsi A; Buhren B; Schrumpf H; Kislat A; Bünemann E; Steinhoff M; Fischer J; Lira SA; Boukamp P; Hevezi P; Stoecklein NH; Hoffmann T; Alves F; Sleeman J; Bauer T; Klufa J; Amberg N; Sibilia M; Zlotnik A; Müller-Homey A; Homey B
    Br J Cancer; 2020 Sep; 123(6):942-954. PubMed ID: 32601464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCL20, a direct-acting pro-angiogenic chemokine induced by hepatitis C virus (HCV): Potential role in HCV-related liver cancer.
    Benkheil M; Van Haele M; Roskams T; Laporte M; Noppen S; Abbasi K; Delang L; Neyts J; Liekens S
    Exp Cell Res; 2018 Nov; 372(2):168-177. PubMed ID: 30287142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-derived CCL20 affects B16 melanoma growth in mice.
    Martin-Garcia D; Silva-Vilches C; Will R; Enk AH; Lonsdorf AS
    J Dermatol Sci; 2020 Jan; 97(1):57-65. PubMed ID: 31883833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CrkL meditates CCL20/CCR6-induced EMT in gastric cancer.
    Han G; Wu D; Yang Y; Li Z; Zhang J; Li C
    Cytokine; 2015 Dec; 76(2):163-169. PubMed ID: 26044596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of CCR6/CCL20/IL-17 axis in NSCLC disease progression.
    Kirshberg S; Izhar U; Amir G; Demma J; Vernea F; Beider K; Shlomai Z; Wald H; Zamir G; Shapira OM; Peled A; Wald O
    PLoS One; 2011; 6(9):e24856. PubMed ID: 21949768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCR6, the sole receptor for the chemokine CCL20, promotes spontaneous intestinal tumorigenesis.
    Nandi B; Pai C; Huang Q; Prabhala RH; Munshi NC; Gold JS
    PLoS One; 2014; 9(5):e97566. PubMed ID: 24866282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-150 inhibits tumor invasion and metastasis by targeting the chemokine receptor CCR6, in advanced cutaneous T-cell lymphoma.
    Ito M; Teshima K; Ikeda S; Kitadate A; Watanabe A; Nara M; Yamashita J; Ohshima K; Sawada K; Tagawa H
    Blood; 2014 Mar; 123(10):1499-511. PubMed ID: 24385540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruption of CCL20-CCR6 interaction inhibits metastasis of advanced cutaneous T-cell lymphoma.
    Ikeda S; Kitadate A; Ito M; Abe F; Nara M; Watanabe A; Takahashi N; Miyagaki T; Sugaya M; Tagawa H
    Oncotarget; 2016 Mar; 7(12):13563-74. PubMed ID: 26789110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CCL20-CCR6 Axis in Cancer Progression.
    Kadomoto S; Izumi K; Mizokami A
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32707869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCL20/CCR6 feedback exaggerates epidermal growth factor receptor-dependent MUC5AC mucin production in human airway epithelial (NCI-H292) cells.
    Kim S; Lewis C; Nadel JA
    J Immunol; 2011 Mar; 186(6):3392-400. PubMed ID: 21300824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCL20/CCR6 axis mediates macrophages to promote proliferation and migration of ESCs by blocking autophagic flux in endometriosis.
    Tan J; Xu T; Gou Y; Wang H; Liang Z; Cao Y; Wang H; Yu Y; Jiao N; Zhang Z
    Stem Cell Res Ther; 2022 Jul; 13(1):294. PubMed ID: 35841069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the CCR6-CCL20 axis prevents regulatory T cell recruitment and sensitizes head and neck squamous cell carcinoma to radiation therapy.
    Rutihinda C; Haroun R; Saidi NE; Ordoñez JP; Naasri S; Lévesque D; Boisvert FM; Fortier PH; Belzile M; Fradet L; Hubert-Tremblay V; Turgeon GA; Wang CS; Delage P; Rousseau É; Paquette B; Oweida AJ
    Cancer Immunol Immunother; 2023 May; 72(5):1089-1102. PubMed ID: 36326893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell differentiation dependent expressed CCR6 mediates ERK-1/2, SAPK/JNK, and Akt signaling resulting in proliferation and migration of colorectal cancer cells.
    Brand S; Olszak T; Beigel F; Diebold J; Otte JM; Eichhorst ST; Göke B; Dambacher J
    J Cell Biochem; 2006 Mar; 97(4):709-23. PubMed ID: 16215992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PPARδ dysregulation of CCL20/CCR6 axis promotes gastric adenocarcinoma carcinogenesis by remodeling gastric tumor microenvironment.
    Liu Y; Wei D; Deguchi Y; Xu W; Tian R; Liu F; Xu M; Mao F; Li D; Chen W; Valentin LA; Deguchi E; Yao JC; Shureiqi I; Zuo X
    Gastric Cancer; 2023 Nov; 26(6):904-917. PubMed ID: 37572185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the CCL20/CCR6 axis in tubular epithelial cell injury: Kidney-specific translational insights from acute kidney injury to chronic kidney disease.
    Yoo KD; Yu MY; Kim KH; Lee S; Park E; Kang S; Lim DH; Lee Y; Song J; Kown S; Kim YC; Kim DK; Lee JS; Kim YS; Yang SH
    FASEB J; 2024 Jan; 38(2):e23407. PubMed ID: 38197598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The CCR6/CCL20 axis mediates Th17 cell migration to the ocular surface in dry eye disease.
    Dohlman TH; Chauhan SK; Kodati S; Hua J; Chen Y; Omoto M; Sadrai Z; Dana R
    Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4081-91. PubMed ID: 23702781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corneal epithelial cells and stromal keratocytes efficently produce CC chemokine-ligand 20 (CCL20) and attract cells expressing its receptor CCR6 in mouse herpetic stromal keratitis.
    Shirane J; Nakayama T; Nagakubo D; Izawa D; Hieshima K; Shimomura Y; Yoshie O
    Curr Eye Res; 2004 May; 28(5):297-306. PubMed ID: 15287366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemokine receptor CCR6 expression level and aggressiveness of prostate cancer.
    Ghadjar P; Loddenkemper C; Coupland SE; Stroux A; Noutsias M; Thiel E; Christoph F; Miller K; Scheibenbogen C; Keilholz U
    J Cancer Res Clin Oncol; 2008 Nov; 134(11):1181-9. PubMed ID: 18465142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CircSMARCC1 facilitates tumor progression by disrupting the crosstalk between prostate cancer cells and tumor-associated macrophages via miR-1322/CCL20/CCR6 signaling.
    Xie T; Fu DJ; Li ZM; Lv DJ; Song XL; Yu YZ; Wang C; Li KJ; Zhai B; Wu J; Feng NH; Zhao SC
    Mol Cancer; 2022 Sep; 21(1):173. PubMed ID: 36045408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DEPDC1 drives hepatocellular carcinoma cell proliferation, invasion and angiogenesis by regulating the CCL20/CCR6 signaling pathway.
    Guo W; Li H; Liu H; Ma X; Yang S; Wang Z
    Oncol Rep; 2019 Sep; 42(3):1075-1089. PubMed ID: 31322256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.